rejuvant life tabs

“Adjust the immune system… de-age the brain”

Latest articles

Paving the way to future organ factories

Extracellular matrix obtained by controlled decellularisation is used to reconstruct the liver with human-like characteristics, paving the way for transplantable livers. Researchers at the Human...

Charles Brenner: the journey from NR to Tru Niagen

Dr Charles Brenner, the developer of the intellectual property behind ChromaDex's Tru Niagen, on all things metabolism, NAD and NR clinical trials. Longevity.Technology: Following the...

Longevity investment firm announces acceleration programme

Call for future founders: longevity investment fund LongeVC announces in-house acceleration programme. LongeVC – a longevity investment group backed by an advisory board with solid...

The placenta: a limitless source of stem cells?

Part 1 of our exclusive interview with Celularity founder Dr Robert Hariri covers the discovery of placental pluripotent stem cells and the journey towards...

Most read

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

David Sinclair to co-chair $200 million biotech SPAC

Christian Angermayer's Frontier Acquisition Corp. holds significant longevity interest with David Sinclair and Peter Attia as Co-Chairs of the Board. Frontier Acquisition Corporation, a special...

JUVICELL sets sights on lifespan and healthspan

Ten ingredients, one capsule. JUVICELL is on a mission to deliver an all-in-one longevity supplement. Far from just supplementing their diet to ensure an adequate...
Supplement report

Editor's picks

Paving the way to future organ factories

Extracellular matrix obtained by controlled decellularisation is used to reconstruct the liver with human-like characteristics, paving the way for transplantable livers. Researchers at the Human...

Charles Brenner: the journey from NR to Tru Niagen

Dr Charles Brenner, the developer of the intellectual property behind ChromaDex's Tru Niagen, on all things metabolism, NAD and NR clinical trials. Longevity.Technology: Following the...

Longevity investment firm announces acceleration programme

Call for future founders: longevity investment fund LongeVC announces in-house acceleration programme. LongeVC – a longevity investment group backed by an advisory board with solid...
Rejuvant

Stanford study finds that blocking certain interactions on immune cells reverses age-related mental decline in older mice.

Stanford University researchers have published a new study in Nature, which shows that restoring the metabolism of certain immune cells reverses cognitive decline in aging mice. In the study, manipulation of myeloid cells was able to restore the youthful metabolism and placid temperament of cells in living mice. This process also reversed age-related mental decline in older mice, restoring their recall and navigation skills to those exhibited by young mice.

“If you adjust the immune system, you can de-age the brain,” said the study’s senior author, Katrin Andreasson, MD, professor of neurology and neurological sciences, also noting that experiments on cells in the lab indicate that similar rejuvenation may be possible in humans.

Longevity.Technology: Targeting chronic inflammation has long been associated with achieving health span and lifespan improvements, and this study adds further weight to the cause. If the Stanford researchers’ findings also apply to humans, this could be a significant step towards the development of new drugs for reversing cognitive decline.

Myeloid cells play a critical role in our immune system and are largely responsible for our body’s defences against many organisms that cause disease; but, in response to the chronic inflammation that is increasingly present in our bodies as we age, myeloid cells inflict collateral damage to innocent tissues in the process. In the brain, this process is linked to increased cognitive decline and conditions including Alzheimer’s disease.

Myeloid cells are the body’s main source of PGE2, a hormone that, among a range of other functions, promotes inflammation. Inflammatory activity is initiated inside the cells after a receptor called EP2 binds to PGE2.

Elevant

 


 

“This powerful pathway drives aging. And it can be downshifted…”

 


 

The researchers found that older cells produced much more PGE2 than younger ones but also had far greater numbers of EP2 on their surfaces. They also found that increased PGE2-EP2 binding caused aging myeloid cells to hoard glucose instead of using it to produce energy. That hoarding, and the cells’ subsequent chronically energy-depleted state, drives them into an “inflammatory rage”, wreaking havoc on aging tissues.

“It’s a double-whammy — a positive feedback loop,” Andreasson said. “This powerful pathway drives aging. And it can be downshifted.”

Elevant

Using two “experimental compounds” that block the PGE2-EP2 reaction on myeloid-cell surfaces in the mice, researchers found that old myeloid cells metabolised glucose like young cells, reversing the old cells’ inflammatory character. Excitingly, these compounds also reversed mice’s age-related cognitive decline, and the older mice who received them performed as well on tests of recall and spatial navigation as young adult mice.

Neither compound is yet approved for human use and, the researchers point out that they simply provide a potential roadmap for drug makers to develop a compound that can hopefully one day be given to people.

Image credit: Steve Fisch
Danny Sullivan
Contributing Editor Danny has worked in technology communications for more than 15 years, spanning Europe and North America. From bionics and lasers to software and pharmaceuticals – and everything in between – he’s covered it all. Danny has wide experience of technology publishing and technical writing and has specific interest in the transfer from idea to market.
Rejuvant

Most popular

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

David Sinclair to co-chair $200 million biotech SPAC

Christian Angermayer's Frontier Acquisition Corp. holds significant longevity interest with David Sinclair and Peter Attia as Co-Chairs of the Board. Frontier Acquisition Corporation, a special...

JUVICELL sets sights on lifespan and healthspan

Ten ingredients, one capsule. JUVICELL is on a mission to deliver an all-in-one longevity supplement. Far from just supplementing their diet to ensure an adequate...

Is nicotinamide riboside a safe and effective way to combat aging?

ChromaDex executive highlights the importance of clinical studies to prove the benefits of NAD+ boosting compound. ChromaDex is the company behind the popular healthy aging...
Supplement report

Related articles

Paving the way to future organ factories

Extracellular matrix obtained by controlled decellularisation is used to reconstruct the liver with human-like characteristics, paving the way for transplantable livers. Researchers at the Human...

The placenta: a limitless source of stem cells?

Part 1 of our exclusive interview with Celularity founder Dr Robert Hariri covers the discovery of placental pluripotent stem cells and the journey towards...

Insulin – predictor of longevity

Body weight stands for far more than simple aesthetics – it is key for longevity. From a single cell to a fully functioning human adult,...

Juvenescence debuts ketosis longevity supplement drink

Biotech Juvenescence's new product Metabolic Switch is a drink that supports healthy aging and a healthy metabolism by generating a state of ketosis. It's been...

Targeting neurodegeneration with $82m Series A

Alchemab raises £60 million to advance novel platform for identifying disease-modifying antibody therapeutics for neurodegeneration, cancer and more. UK-based biotech Alchemab Therapeutics has secured a...
Supps report ad middle